127 related articles for article (PubMed ID: 11109196)
1. [Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors].
Benvenuto GM; La Vecchia L; Morandi P; Ruffini P; Mezzena G
Ital Heart J Suppl; 2000 Nov; 1(11):1457-63. PubMed ID: 11109196
[TBL] [Abstract][Full Text] [Related]
2. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
[TBL] [Abstract][Full Text] [Related]
3. Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation.
Zver S; Zadnik V; Černelč P; Koželj M
Int J Hematol; 2008 Sep; 88(2):227-236. PubMed ID: 18548196
[TBL] [Abstract][Full Text] [Related]
4. Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
Zver S; Zadnik V; Bunc M; Rogel P; Cernelc P; Kozelj M
Int J Hematol; 2007 Jun; 85(5):408-14. PubMed ID: 17562616
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
6. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
Veronese P; Hachul DT; Scanavacca MI; Hajjar LA; Wu TC; Sacilotto L; Veronese C; Darrieux FCDC
PLoS One; 2018; 13(5):e0196763. PubMed ID: 29723224
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
Feola M; Garrone O; Occelli M; Francini A; Biggi A; Visconti G; Albrile F; Bobbio M; Merlano M
Int J Cardiol; 2011 Apr; 148(2):194-8. PubMed ID: 19945181
[TBL] [Abstract][Full Text] [Related]
8. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer.
Tiersten A; Wo J; Jacobson C; Weitzman A; Horwich T; Hesdorffer C; Savage D; Troxel A
Breast; 2004 Aug; 13(4):341-6. PubMed ID: 15325671
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
Selim NA; Hmouda HT
Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
[TBL] [Abstract][Full Text] [Related]
10. Troponin I as a marker of doxorubicin induced cardiotoxicity.
Polena S; Shikara M; Naik S; Chouhdry F; Sharma M; Gintautas J; Maniar R
Proc West Pharmacol Soc; 2005; 48():142-4. PubMed ID: 16416682
[TBL] [Abstract][Full Text] [Related]
11. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
12. Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction.
Kittiwarawut A; Vorasettakarnkij Y; Tanasanvimon S; Manasnayakorn S; Sriuranpong V
Asia Pac J Clin Oncol; 2013 Jun; 9(2):155-61. PubMed ID: 22897825
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.
Braverman AC; Antin JH; Plappert MT; Cook EF; Lee RT
J Clin Oncol; 1991 Jul; 9(7):1215-23. PubMed ID: 2045862
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.
Onitilo AA; Engel JM; Stankowski RV; Liang H; Berg RL; Doi SA
Breast Cancer Res Treat; 2012 Jul; 134(1):291-8. PubMed ID: 22476854
[TBL] [Abstract][Full Text] [Related]
15. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
16. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
17. Signs of myocardial ischemia on electrocardiogram correlate with elevated plasma cardiac troponin and right ventricular systolic dysfunction in acute pulmonary embolism.
Kostrubiec M; Jankowski K; Pedowska-Włoszek J; Puncewicz B; Pacho S; Lichodziejewska B; Labyk A; Hrynkiewicz-Szymańska A; Pruszczyk P
Cardiol J; 2010; 17(2):157-62. PubMed ID: 20544614
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines.
Specchia G; Buquicchio C; Pansini N; Di Serio F; Liso V; Pastore D; Greco G; Ciuffreda L; Mestice A; Liso A
J Lab Clin Med; 2005 Apr; 145(4):212-20. PubMed ID: 15962840
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular diastolic dysfunction induced by cyclophosphamide in blood stem cell transplantation.
Mori T; Yanagi N; Maruyama T; Gondo H; Okamura T; Kaji Y; Harada M
Jpn Heart J; 2002 May; 43(3):249-61. PubMed ID: 12227700
[TBL] [Abstract][Full Text] [Related]
20. Myocardial injury in scorpion envenomed children: significance of assessment of serum troponin I and interleukin-8.
Meki AR; El-Deen ZM; El-Deen HM
Neuro Endocrinol Lett; 2002 Apr; 23(2):133-40. PubMed ID: 12011799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
